Clinical Trials Logo

Clinical Trial Summary

To screen a dose-dense arm to be used in a future large scale phase III trial. Primary endpoint is safety; secondary endpoints are disease free survival and overall survival. A total of 100 patients were included.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00189670
Study type Interventional
Source Association Européenne de Recherche en Oncologie
Contact
Status Completed
Phase Phase 2

See also
  Status Clinical Trial Phase
Completed NCT02348684 - Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation
Completed NCT03413761 - Antioxidant Supplements, Genetics and Chemotherapy Outcomes